| |
| |
|
| Insider
Information: |
Veneman Ann M |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
5,480 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,000,100 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,480 |
|
|
| Total
Value |
$1,000,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-09-05 |
5,480 |
2010-05-28 |
0 |
Premium* |
|
|
Icosavax, Inc. |
ICVX |
|
2024-02-19 |
0 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,834) |
0 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,209) |
0 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Director |
– • – |
2021-07-30 |
4 |
A |
$15.00 |
$127,500 |
D/D |
8,500 |
8,500 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-09-05 |
4 |
AS |
$145.81 |
$121,751 |
D/D |
(835) |
5,480 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-07-31 |
4 |
AS |
$137.74 |
$96,418 |
D/D |
(700) |
6,315 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
7,015 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
4,985 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
S |
$187.48 |
$167,795 |
D/D |
(895) |
3,252 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
4,147 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-12-11 |
4 |
S |
$193.03 |
$238,392 |
D/D |
(1,235) |
3,447 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-06-04 |
4 |
S |
$170.01 |
$210,132 |
D/D |
(1,236) |
4,682 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
6,813 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-04-29 |
4 |
S |
$99.00 |
$308,385 |
D/D |
(3,115) |
5,918 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
9,033 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-12-12 |
4 |
S |
$95.00 |
$435,005 |
D/D |
(4,579) |
6,562 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,115 |
8,128 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,725 |
5,013 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-05-28 |
4 |
A |
$50.03 |
$114,469 |
D/D |
2,288 |
2,288 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
